Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Poole-Wilson

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Revista Espanola De Cardiologia|December 1, 1995
[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)]G de Backer, I Graham, P Poole-Wilson, et al.
Heart (British Cardiac Society)|November 7, 2006
Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic timeT V Salukhe, K Dimopoulos, R Sutton, et al.
European Heart Journal|August 26, 1998
Quantitation of left ventricular volumes and ejection fraction in post-infarction patients from biplane and single plane two-dimensional echocardiograms. A prospective longitudinal study of 371 patientsM St John Sutton, J E Otterstat, T Plappert, et al.
The American Journal of Cardiology|October 22, 1998
Impaired baroreflex sensitivity and sympathovagal balance in syndrome XS Adamopoulos, G M Rosano, P Ponikowski, et al.
Lancet (London, England)|September 13, 2005
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trialK A A Fox, P Poole-Wilson, T C Clayton, et al.
Deutsche Medizinische Wochenschrift (1946)|September 29, 2005
[Adherence to guidelines in CHF therapy in Germany]M Flesch, M Komajda, P Lapuerta, et al.
Journal of Cardiac Failure|July 15, 1999
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE IIB Pitt, P Poole-Wilson, R Segal, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Revista Espanola De Cardiologia|December 1, 1995
[Prevention of coronary disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology (ESC), European Atherosclerosis Society (EAS) and European Society of Hypertension (ESH)]G de Backer, I Graham, P Poole-Wilson, et al.
Heart (British Cardiac Society)|November 7, 2006
Instantaneous effects of resynchronisation therapy on exercise performance in heart failure patients: the mechanistic role and predictive power of total isovolumic timeT V Salukhe, K Dimopoulos, R Sutton, et al.
European Heart Journal|August 26, 1998
Quantitation of left ventricular volumes and ejection fraction in post-infarction patients from biplane and single plane two-dimensional echocardiograms. A prospective longitudinal study of 371 patientsM St John Sutton, J E Otterstat, T Plappert, et al.
The American Journal of Cardiology|October 22, 1998
Impaired baroreflex sensitivity and sympathovagal balance in syndrome XS Adamopoulos, G M Rosano, P Ponikowski, et al.
Lancet (London, England)|September 13, 2005
5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trialK A A Fox, P Poole-Wilson, T C Clayton, et al.
Deutsche Medizinische Wochenschrift (1946)|September 29, 2005
[Adherence to guidelines in CHF therapy in Germany]M Flesch, M Komajda, P Lapuerta, et al.
Journal of Cardiac Failure|July 15, 1999
Effects of losartan versus captopril on mortality in patients with symptomatic heart failure: rationale, design, and baseline characteristics of patients in the Losartan Heart Failure Survival Study--ELITE IIB Pitt, P Poole-Wilson, R Segal, et al.
Pageof 4